BioLife Solutions Inc Trading 3.58 percent Higher on Jul 2
| BLFS Stock | USD 20.89 0.08 0.38% |
Slightly above 54% of BioLife Solutions' investor base is interested to short. The analysis of overall sentiment of trading BioLife Solutions stock suggests that many investors are impartial at this time. BioLife Solutions' investing sentiment can be driven by a variety of factors including economic data, BioLife Solutions' earnings reports, geopolitical events, and overall market trends.
Shares of BioLife Solutions Inc surged 3.58 percent in mid-day trading on Jul 2. The stock reached an intraday high of 22.73, before settling at 22.44, up
Read at gurufocus.com
 |
BioLife Solutions Fundamental Analysis
We analyze BioLife Solutions' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioLife Solutions using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioLife Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
BioLife Solutions is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
BioLife Solutions Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioLife Solutions stock to make a market-neutral strategy. Peer analysis of BioLife Solutions could also be used in its relative valuation, which is a method of valuing BioLife Solutions by comparing valuation metrics with similar companies.
Peers
BioLife Solutions Related Equities
| ATRC | AtriCure | 5.64 | ||||
| VCEL | Vericel Corp | 5.47 | ||||
| CDNA | CareDx | 3.11 | ||||
| RGNX | Regenxbio | 1.71 | ||||
| ANGO | AngioDynamics | 1.29 | ||||
| COO | Cooper Companies, | 0.82 | ||||
| AXGN | Axogen | 0.95 | ||||
| CYRX | Cryoport | 1.51 | ||||
| ATR | AptarGroup | 1.57 |
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.